Searchable abstracts of presentations at key conferences in endocrinology

ea0020p58 | Thyroid | ECE2009

The influence of thyroxine replacement therapy on bone mineral density in hypothyroid subjects

Polovina Snezana , Nemet Klara Tucic , Pletikosic Ivana , Obradovic Angelina

Recent studies have suggested that subjects receiving thyroxine replacement therapy are in potentially increased risk of osteoporosis. We set out to measure bone mineral densities by ultrasound bone densitometry (UBMD) in three groups: group A of post-menopausal women (N=25) mean age 65 (±14), group B of women in generative period (N=20) mean age 41(±11), and group C (N=18) male mean age 54, receiving thyroxine replacement therapy during two year...

ea0022p614 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Risk factors for development of atherosclerosis in young women with hyperprolatinemia

Medic-Stojanoska Milica , Pletikosic Ivana , Kovacev-Zavisic Branka , Todorovic-Djilas Ljiljana , Vukovic Bojan , Icin Tijana , Bajkin Ivana , Novakovic-Paro Jovanka

Metabolic and immunological disturbances may be associated with hyperprolactinemia.Aim: The aim of this study was examination the presence of some metabolic and immunological disturbances, like as the changes in and body composition, as risk factors for development of atherosclerosis, in young women with hyperprolactinemia.Material and methods: The investigation was performed as prospective study in a group of 20 premenopausal wome...